Hiroyoshi Nishikawa
Hiroyoshi Nishikawa publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses and Immune Cell Function and Interaction.
- World rank
- #52,792 of 7,710,434 ranked researchers
- Rank in Japan
- #282 of 383,136
- Works
- 706
- Citations
- 27k
- Citations per work
- 38.4
What does Hiroyoshi Nishikawa research?
Hiroyoshi Nishikawa's work is mostly in Medicine (40%), Immunology and Microbiology (32%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences28440.2%
- Medicine28440.2%
- Life Sciences27338.7%
- Everything else14921.1%
- 1Immunology32% of their works
- 2Oncology28% of their works
- 3Molecular Biology7% of their works
- 4Pulmonary and Respiratory Medicine6% of their works
- 5Surgery4% of their works
- 6Radiology, Nuclear Medicine and Imaging2% of their works
Research topics
Which keywords describe Hiroyoshi Nishikawa's research?
The keywords of their largest research topics: Cancer Immunotherapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Dendritic Cells, Immunity, Natural Killer Cells, NK Cell Recognition and Foxp3.
- Therapeutic Antibodies
- KRAS Mutations
- Endoscopic Resection
- Chemotherapy
- CAR T Cells
- Foxp3
- NK Cell Recognition
- Dendritic Cells
- Immune Checkpoint Blockade
- Cancer Immunotherapy
- PD-1 and PD-L1
- Immunity
- Natural Killer Cells
- TGF-ß
- Chimeric Antigen Receptor
- Cetuximab
- Gastric Cancer
- Fc Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Cancer Immunotherapy1512 topics
- Immune Checkpoint Blockade1461 topic
- PD-1 and PD-L11461 topic
- Dendritic Cells1041 topic
- Immunity1041 topic
- NK Cell Recognition961 topic
- Natural Killer Cells961 topic
- Foxp3571 topic
- TGF-ß571 topic
- CAR T Cells471 topic
- Chimeric Antigen Receptor471 topic
- Chemotherapy422 topics
- Cetuximab211 topic
- Endoscopic Resection211 topic
- Gastric Cancer211 topic
- KRAS Mutations211 topic
- Fc Receptors181 topic
- Therapeutic Antibodies181 topic
Where does Hiroyoshi Nishikawa work?
Hiroyoshi Nishikawa's main affiliation in the publication record is Nagoya University, Japan.
How many publications and citations does Hiroyoshi Nishikawa have?
OpenAlex counts 706 works and 27,086 citations for Hiroyoshi Nishikawa, an h-index of 65, ranking #52,792 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hiroyoshi Nishikawa. Posts are plain text and can be reported.